{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T03:54:03Z","timestamp":1793850843279,"version":"4.6.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.pharmthera.2005.05.002","type":"journal-article","created":{"date-parts":[[2005,6,24]],"date-time":"2005-06-24T13:41:54Z","timestamp":1119620514000},"page":"308-319","source":"Crossref","is-referenced-by-count":301,"title":["FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors"],"prefix":"10.1016","volume":"108","author":[{"given":"Kenji","family":"Chiba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2005.05.002_bib1","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/0960-894X(95)00127-F","article-title":"Design, synthesis and structure\u2013activity relationships of 2-substituted-2-amino-1.3-propanediols: discovery of a novel immunosuppressant, FTY720","volume":"5","author":"Adachi","year":"1995","journal-title":"Biomed Chem Lett"},{"key":"10.1016\/j.pharmthera.2005.05.002_bib2","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0952-7915(02)00374-6","article-title":"FTY720: target G-protein-coupled receptors for sphingosine 1-phosphate in transplantation and autoimmunity","volume":"14","author":"Brinkmann","year":"2002","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.pharmthera.2005.05.002_bib3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0165-6147(99)01419-4","article-title":"FTY720: a novel transplantation drug that modulates lymphocyte traffic rather than activation","volume":"21","author":"Brinkmann","year":"2000","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.05.002_bib4","doi-asserted-by":"crossref","first-page":"21453","DOI":"10.1074\/jbc.C200176200","article-title":"The immune modulator FTY720 targets sphingosine 1-phosphate receptors","volume":"277","author":"Brinkmann","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.05.002_bib5","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1600-6143.2004.00476.x","article-title":"FTY720: sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endotherial barrier function","volume":"4","author":"Brinkmann","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.pharmthera.2005.05.002_bib6","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1681\/ASN.V1341073","article-title":"Fuman first trail of FTY720, a novel immunomodulator, in stable renal transplant patients","volume":"13","author":"Budde","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2005.05.002_bib7","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1034\/j.1600-6143.2003.00130.x","article-title":"Pharmacodynamics of single doses of the novel immunosuppressant FTY720 in stable renal transplant patients","volume":"3","author":"Budde","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.pharmthera.2005.05.002_bib8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1358\/dof.1997.022.01.391380","article-title":"FTY720, immunosuppressant","volume":"22","author":"Chiba","year":"1997","journal-title":"Drugs Future"},{"key":"10.1016\/j.pharmthera.2005.05.002_bib9","first-page":"1056","article-title":"FTY720, a novel immunosuppressant possessing unique mechanisms: I. Prolongation of skin allograft survival and synergistic effect in combination with cyclosporin A in rats","volume":"28","author":"Chiba","year":"1996","journal-title":"Transplant Proc"},{"key":"10.1016\/j.pharmthera.2005.05.002_bib10","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.4049\/jimmunol.160.10.5037","article-title":"FTY720, a novel immunosuppressant, induces sequestration of circulating mature-lymphocytes by acceleration of lymphocyte homing in rats: I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing","volume":"160","author":"Chiba","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.pharmthera.2005.05.002_bib11","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/S0041-1345(98)01975-7","article-title":"FTY720, a novel immunosuppressant, induces sequestration of circulating lymphocytes by acceleration of lymphocyte homing","volume":"31","author":"Chiba","year":"1999","journal-title":"Transplant Proc"},{"key":"10.1016\/j.pharmthera.2005.05.002_bib12","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.transproceed.2004.12.286","article-title":"Immunosuppressive activity of FTY720, sphingosine 1-phosphate receptor agonist: I. Prevention of allograft rejection in rats and dogs by FTY720 and FTY720-phosphate","volume":"37","author":"Chiba","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.pharmthera.2005.05.002_bib13","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1124\/jpet.102.045658","article-title":"Amelioration of experimental autoimmune encephalomyelitis in Lewis rats by FTY720 treatment","volume":"305","author":"Fujino","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.05.002_bib14","doi-asserted-by":"crossref","first-page":"208","DOI":"10.7164\/antibiotics.47.208","article-title":"Fungal metabolites: Part 11. A potent immunosuppressive activity found in Isaria sinclairii metabolite","volume":"47","author":"Fujita","year":"1994","journal-title":"J Antibiotics"},{"key":"10.1016\/j.pharmthera.2005.05.002_bib15","doi-asserted-by":"crossref","first-page":"216","DOI":"10.7164\/antibiotics.47.216","article-title":"Fungal metabolites: Part 12. Potent immunosuppressant, 14-deoxomyruiocin, (2S,3R,4R)-(E)-2-amino-3,4-dihydroxy-2-hydroxymethyleicos-6-enoic acid and structure\u2013activity relationships of myriocin derivatives","volume":"47","author":"Fujita","year":"1994","journal-title":"J Antibiotics"},{"key":"10.1016\/j.pharmthera.2005.05.002_bib16","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/0960-894X(95)00126-E","article-title":"Simple compounds, 2-alkyl-2-amino-1,3-propane-diols have potent immunosuppressive activity","volume":"5","author":"Fujita","year":"1995","journal-title":"Biomed Chem Lett"},{"key":"10.1016\/j.pharmthera.2005.05.002_bib17","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.1021\/jm960391l","article-title":"Potent immunosuppressants, 2-alkyl-2-aminopropane-1, 3-diols","volume":"39","author":"Fujita","year":"1996","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmthera.2005.05.002_bib18","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1096\/fj.03-0910fje","article-title":"The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G-protein-coupled receptors","volume":"18","author":"Graler","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/j.pharmthera.2005.05.002_bib19","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1016\/S0960-894X(96)00487-8","article-title":"2-Aminoalcohol immunosuppressants: structure\u2013activity relationships","volume":"6","author":"Hirose","year":"1996","journal-title":"Biomed Chem Lett"},{"key":"10.1016\/j.pharmthera.2005.05.002_bib20","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1126\/science.1065323","article-title":"Lysophospholipids-receptor revelations","volume":"294","author":"Hla","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.05.002_bib21","first-page":"1060","article-title":"FTY720, a novel immunosuppressant possessing unique mechanisms: II. Long-term graft survival induction in rat hetrotopic cardiac allograft and synergistic effect in combination with cyclosporin A","volume":"28","author":"Hoshino","year":"1996","journal-title":"Transplant Proc"},{"key":"10.1016\/j.pharmthera.2005.05.002_bib22","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/S0041-1345(98)01973-3","article-title":"FTY720, a novel immunosuppressant, shows a synergistic effect in combination with FK506 in rat allograft models","volume":"31","author":"Hoshino","year":"1999","journal-title":"Transplant Proc"},{"key":"10.1016\/j.pharmthera.2005.05.002_bib23","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1097\/01.TP.0000084822.01372.AC","article-title":"Pharmacodynamics, pharmacokinetics, and safety of multiple doses of FTY720 in stable renal transplant patients: a multicenter, randomized, placebo-controlled, phase I study","volume":"76","author":"Kahan","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.pharmthera.2005.05.002_bib24","first-page":"87","article-title":"The therapeutic effect of FTY720 on experimental autoimmune encephalomyelitis in mice","volume":"2004","author":"Kataoka","year":"2004","journal-title":"Immunology"},{"key":"10.1016\/j.pharmthera.2005.05.002_bib25","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.transproceed.2004.12.287","article-title":"Immunosuppressive activity of FTY720, sphingosine 1-phosphate receptor agonist: II. Effect of FTY720 and FTY720-phosphate on host-versus-graft and graft-versus-host reaction in mice","volume":"37","author":"Kataoka","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.pharmthera.2005.05.002_bib26","first-page":"1062","article-title":"FTY720, a novel immunosuppressant possessing unique mechanisms: III. Synergistic prolongation of canine renal allograft survival in combination with cyclosporin A","volume":"28","author":"Kawaguchi","year":"1996","journal-title":"Transplant Proc"},{"key":"10.1016\/j.pharmthera.2005.05.002_bib27","doi-asserted-by":"crossref","first-page":"31780","DOI":"10.1074\/jbc.M104353200","article-title":"Sphingosine 1-phosphate may be a major component of plasma lipoproteins responsible for the cytoprotective actions in human umbilical vein endotherial cells","volume":"276","author":"Kimura","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.05.002_bib28","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1021\/jm000173z","article-title":"Synthesis and immunosuppressive activity of 2-substituted 2-aminopropane-1,3-diols and 2-aminoethanols","volume":"43","author":"Kiuchi","year":"2000","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmthera.2005.05.002_bib29","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.bmc.2004.10.008","article-title":"Asymmetric synthesis and biological evaluation of the enantiomeric isomer of immunosuppressive FTY720-phosphate","volume":"13","author":"Kiuchi","year":"2005","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.pharmthera.2005.05.002_bib30","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1124\/jpet.301.2.519","article-title":"Pharmacokinetics and cell trafficking dynamics of 2-amino-2-[2-(4-octylphenyl) ethyl]propane-1,3-diol hydrochloride (FTY720) in cynomolgus monkeys after single oral and intravenous doses","volume":"301","author":"Li","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.05.002_bib31","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1084\/jem.20041509","article-title":"Cyclical modulation of sphingosine-1-phosphate receptor 1 surface expression during lymphocyte recirculation and relationship to lymphoid organ transit","volume":"201","author":"Lo","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.pharmthera.2005.05.002_bib32","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1126\/science.1070238","article-title":"Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists","volume":"296","author":"Mandala","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.05.002_bib33","first-page":"1064","article-title":"FTY720, a novel immunosuppressant possessing unique mechanisms: IV. Prevention of graft versus host reactions in rats","volume":"28","author":"Masubuchi","year":"1996","journal-title":"Transplant Proc"},{"key":"10.1016\/j.pharmthera.2005.05.002_bib34","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nature02284","article-title":"Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1","volume":"427","author":"Matloubian","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.05.002_bib35","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s000110050608","article-title":"Effect of FTY720, a novel immunosuppressant, on adjuvant-induced arthritis in rats","volume":"49","author":"Matsuura","year":"2000","journal-title":"Inflamm Res"},{"key":"10.1016\/j.pharmthera.2005.05.002_bib36","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0192-0561(99)00088-0","article-title":"Effect of FTY720, a novel imunosuppressant, on adjuvant- and collagen-induced arthritis in rats","volume":"22","author":"Matsuura","year":"2000","journal-title":"Int J Immunopharmacol"},{"key":"10.1016\/j.pharmthera.2005.05.002_bib37","first-page":"707","article-title":"Effect of FTY720 in MRL-lpr\/lpr mice: therapeutic potential in systemic lupus erythematosus","volume":"29","author":"Okazaki","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.pharmthera.2005.05.002_bib38","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0014-5793(03)01168-2","article-title":"The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2","volume":"554","author":"Paugh","year":"2003","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pharmthera.2005.05.002_bib39","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0163-7258(00)00084-X","article-title":"Sphingosine 1 phosphate signaling via the endotherial differentiation gene family of G-protein-coupled receptors","volume":"88","author":"Pyne","year":"2000","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2005.05.002_bib40","doi-asserted-by":"crossref","first-page":"420","DOI":"10.7164\/antibiotics.47.420","article-title":"Fungal metabolites: Part 14. Novel potent immunosuppressants, mycestericins, produced by Mycelia sterilia","volume":"47","author":"Sasaki","year":"1994","journal-title":"J Antibiot"},{"key":"10.1016\/j.pharmthera.2005.05.002_bib41","first-page":"271","article-title":"The therapeutic effect of FTY720 on lupus nephritis in aoutoimmune MRL\/lpr mice","volume":"2004","author":"Sugahara","year":"2004","journal-title":"Immunology"},{"key":"10.1016\/j.pharmthera.2005.05.002_bib42","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/00007890-199601270-00006","article-title":"A novel immunosuppressant, FTY720, having an unique mechanism of action induces long-term graft acceptance in rat and dog allotransplantation","volume":"61","author":"Suzuki","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.pharmthera.2005.05.002_bib43","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1046\/j.1365-2567.1996.d01-777.x","article-title":"A new immunosuppressant, FTY720 induces bcl-2-associated apoptotic cell death in human lymphocytes","volume":"89","author":"Suzuki","year":"1996","journal-title":"Immunology"},{"key":"10.1016\/j.pharmthera.2005.05.002_bib44","first-page":"95","article-title":"An immunosuppressive regime using FTY720 combined with cyclosporin in canine kidney transplantation","volume":"11","author":"Suzuki","year":"1998","journal-title":"Transpl Int"},{"key":"10.1016\/j.pharmthera.2005.05.002_bib45","first-page":"1826","article-title":"FTY720, a novel immunomodulator: efficacy and safety results from the first phase 2a study in de novo renal transplantation","volume":"77","author":"Tedesco-Silva","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.pharmthera.2005.05.002_bib46","first-page":"864","article-title":"FTY720, a novel immunosuppressant, possessing unique mechanisms: III. Pharmacological activities in several autoimmune and inflammatory models","volume":"9","author":"Teshima","year":"1995","journal-title":"Int Congr Immunol"},{"key":"10.1016\/j.pharmthera.2005.05.002_bib47","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00007890-199901150-00024","article-title":"Prophylaxis of acute renal allograft rejection using FTY720 in combination with subtherapeutic doses of cyclosporine","volume":"67","author":"Troncoso","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.pharmthera.2005.05.002_bib48","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/(SICI)1521-4141(200005)30:5<1435::AID-IMMU1435>3.0.CO;2-O","article-title":"Immunosuppressant FTY720 inhibits thymocyte emigration","volume":"30","author":"Yagi","year":"2000","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.pharmthera.2005.05.002_bib49","doi-asserted-by":"crossref","first-page":"5493","DOI":"10.4049\/jimmunol.160.11.5493","article-title":"FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats: II. FTY720 prolongs skin allograft survival by preventing infiltration of T cells into the grafts, but not production of cytokines in vivo","volume":"160","author":"Yanagawa","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.pharmthera.2005.05.002_bib50","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1046\/j.1365-2567.1998.00639.x","article-title":"FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats: III. Increase in frequency of CD62L-positive T cells in Peyer's patches by FTY720-induced lymphocyte homing","volume":"95","author":"Yanagawa","year":"1998","journal-title":"Immunology"},{"key":"10.1016\/j.pharmthera.2005.05.002_bib51","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/S0041-1345(98)01974-5","article-title":"FTY720, a novel immunosuppressant, prolongs rat skin allograft survival by decreasing T cell infiltration into grafts","volume":"31","author":"Yanagawa","year":"1999","journal-title":"Transplant Proc"},{"key":"10.1016\/j.pharmthera.2005.05.002_bib52","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0192-0561(00)00022-9","article-title":"The significance of timing of FTY720 administration on the immunosuppressive effect to prolong rat skin allograft survival","volume":"22","author":"Yanagawa","year":"2000","journal-title":"Int J Immunopharmacol"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725805000987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725805000987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,27]],"date-time":"2024-01-27T04:36:18Z","timestamp":1706330178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725805000987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S0163725805000987"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2005.05.002","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}